Target intelligence / Profile preview

Elongation factor G (EF-G) – ribosome complex (EF-G – ribosome complex)

Target
EF-G – ribosome complex
Molecular classification
GTPase, Translation factor, Ribonucleoprotein complex, Enzyme
01

Overview

The Elongation factor G (EF-G) – ribosome complex is a fundamental component of the bacterial protein synthesis machinery, responsible for the translocation step of translation (UniProt, 2024). Elongation factor G, a translational GTPase encoded by the fusA gene, binds to the ribosome and utilizes the energy from GTP hydrolysis to move the mRNA and tRNAs through the ribosomal subunits, a process essential for the continuous elongation of the polypeptide chain (PubMed, 2023). This complex serves as a primary target for several classes of antibiotics, most notably the steroid-like antibiotic fusidic acid, which prevents the release of EF-G from the ribosome after GTP hydrolysis (StatPearls, 2024). By stalling the ribosome in a post-translocational state, these drugs effectively inhibit bacterial growth and protein production. Mutations in the fusA gene are a common mechanism of clinical resistance, often reducing the affinity of the drug for the complex (NIH, 2022). Additionally, the complex plays a role in ribosome recycling, where EF-G works alongside ribosome recycling factor (RRF) to disassemble the post-termination complex. Given its essentiality in bacteria and structural differences from eukaryotic counterparts, it remains a key focus for antimicrobial drug discovery and structural biology research.

Other names
EF-GTranslocaseG-factorFusABacterial elongation factor GRibosome-EF-G complex
02

Mechanism of action

Inhibition of the translocation step of protein synthesis by stabilizing the EF-G-GDP complex on the ribosome or preventing EF-G binding to the ribosomal A-site.

03

Biological functions

Protein synthesisTranslocationRibosome recyclingGTP hydrolysis
04

Disease associations

Bacterial infection
05

Safety considerations

Antimicrobial resistance developmentPotential cross-reactivity with human mitochondrial elongation factor G1 (GFM1)Limited spectrum of activity (primarily Gram-positive)
06

Interacting drugs

Fusidic acid

3 more in the full profile.

07

Biomarkers

Bacterial growth inhibitionMinimum inhibitory concentration (MIC)fusA gene mutations

Beyond the preview

Go deeper on Elongation factor G (EF-G) – ribosome complex (EF-G – ribosome complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongation factor G (EF-G) – ribosome complex (EF-G – ribosome complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call